Sarah Haverin graduated from Monash University with a triple major in Molecular Biology, Microbiology, and Genetics. Commencing her career in medical research at the Monash Institute for Medical Research, and later, Monash University, Sarah worked on projects related to neurodegeneration, breast cancer, and diabetes.
After obtaining an M.B.A. from Texas State University in 2012 Sarah worked for Emergo; a medical device RA/QA consulting company. Sarah moved to Oriel STAT A MATRIX, a global provider of medical device RA/QA training and consulting services, in 2015. During her time with both consulting companies Sarah has worked with hundreds of medical device manufacturers of all sizes to provide strategic RA/QA advice, support the introduction of new devices, help manufacturers to navigate new and complex regulatory requirements, and resolve disputes with regulators.